Abstract: The present disclosure relates to a system for predicting the magnitude of ultrafiltration volume expected in a peritoneal dialysis treatment for an individual patient, the system comprising:—a peritoneal treatment machine configured to perform cycles of a peritoneal treatment performed on the patient according to a prescription by controlling at least one actuator and/or valve of the peritoneal treatment machine, the cycles comprising a fill phase, a dwell phase and a drain phase,—a sensor for repeatedly measuring a sensed value during the treatment performed on the patient,—a controller programmed to predict the magnitude of ultrafiltration volume expected during a treatment performed according to a prescription based on a model of ultrafiltration, and to fit parameter values of the model to the individual patient based on the values measured by the sensor, wherein the model of ultrafiltration uses a patient-specific aggregated reflection coefficient as a parameter representing the overall average effect of

Abstract: This disclosure teaches methods and systems for determining membrane transport parameters of a peritoneal dialysis (PD) patient, and updating a (PD) prescription of the patient based on one or more of the membrane transport parameters. The methods include withdrawing a plurality of samples of PD effluent from the patient's peritoneal cavity periodically during one or more dwell phases of one or more PD treatment cycles. The method further includes obtaining sensor measurements of the samples of PD effluent, determining one or more peritoneal membrane transport parameters based on the sensor measurements, and updating the patient's PD prescription, to be used for a later peritoneal dialysis treatment, based on the one or more peritoneal membrane transport parameters.

Abstract: This disclosure provides methods and systems for peritoneal dialysis (PD) effluent sampling and measurement, which are compatible with all types of PD treatment, and would enable more frequent assessment so a patient's PD prescription can be updated routinely. The methods include withdrawing a plurality of samples of PD effluent from the patient's peritoneal cavity periodically during the dwell phase of a PD treatment cycle. The method further includes obtaining sensor measurements of the samples of PD effluent. The method may return each PD effluent sample to the patient's peritoneal cavity after the measurement. Alternatively, the PD effluent samples may be stored in a container without returning them to the patient's peritoneal cavity.

Abstract: A medical treatment machine, such as a home dialysis machine, can receive prescription parameters that define parameters of a medical treatment to be administered to a patient. A medical prescription is entered by a clinician into a clinical information system (CIS) that calls a system to evaluate the compatibility of the entered prescription by transmitting the prescription parameters to a server that has access to a database of medical devices and their operational parameters. The server compares the treatment parameters of the medical prescription to the operational parameters of the medical device and generates a prescription compatibility response indicting if the treatment parameters of the medical prescription can be executed by the medical device. The server returns to the CIS the prescription compatibility response to allow the prescription, e.g. in a digital or program form, to be securely transmitted or delivered via a connected health system to the medical device.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: Disclosed herein are embodiments of a device that can be powered or charged via ultrasonic energy conducted from another device via a fluid connection. In particular, disclosed herein is a pressure sensor for use with an automatic peritoneal dialysis (APD) cycler wherein power is transferred from the APD cycler to the sensor via ultrasonic wave transmitted through a dialysate fluid. A piezoelectric transducer is used in the device to convert the kinetic energy of the ultrasonic waves in to electrical energy that can be used to power the device or charge a power storage element within the device.

Abstract: A medical treatment machine, such as a home dialysis machine, can receive prescription parameters that define parameters of a medical treatment to be administered to a patient. A medical prescription is entered by a clinician into a clinical information system (CIS) that calls a system to evaluate the compatibility of the entered prescription by transmitting the prescription parameters to a server that has access to a database of medical devices and their operational parameters. The server compares the treatment parameters of the medical prescription to the operational parameters of the medical device and generates a prescription compatibility response indicting if the treatment parameters of the medical prescription can be executed by the medical device. The server returns to the CIS the prescription compatibility response to allow the prescription, e.g. in a digital or program form, to be securely transmitted or delivered via a connected health system to the medical device.

Abstract: The present invention relates to an apparatus for performing peritoneal dialysis, the apparatus comprising means for delivering dialysis fluid to the peritoneal cavity of a patient, a measurement device for measuring the fluid pressure of the delivered dialysis fluid and/or the fluid pressure in the peritoneal cavity, i.e. the intraperitoneal pressure and/or any pressure related thereto, and a control unit operably connected to said means and the measurement device, wherein the control unit is configured to effect an inflow or outflow phase encompassing a series of fill-and-measurement or drain-and-measurement steps, each step comprising delivering a predetermined quantity of dialysis fluid to the peritoneal cavity or draining a predetermined quantity of dialysis fluid from the peritoneal cavity and subsequently measuring and recording a pressure value.

Abstract: A medical treatment machine, such as a home dialysis machine, can receive prescription parameters that define parameters of a medical treatment to be administered to a patient. A medical prescription is entered by a clinician into a clinical information system (CIS) that calls a system to evaluate the compatibility of the entered prescription by transmitting the prescription parameters to a server that has access to a database of medical devices and their operational parameters. The server compares the treatment parameters of the medical prescription to the operational parameters of the medical device and generates a prescription compatibility response indicting if the treatment parameters of the medical prescription can be executed by the medical device. The server returns to the CIS the prescription compatibility response to allow the prescription, e.g. in a digital or program form, to be securely transmitted or delivered via a connected health system to the medical device.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: The disclosure relates to new methods for calibrating or adjusting a bioimpedance measuring device. Furthermore, the present disclosure relates to a medical set or system, a medical measuring standard, a method for testing a bioimpedance measuring device, and a bioimpedance measuring device.

Abstract: The described technology generally includes systems and processes for a PD optimization process may operate to estimate, predict, or otherwise determine the value of PD dose variables values based on patient characteristics and/or PD prescription information. In one embodiment, a PD optimization process may be or may include a UFV determination process, operative to determine a predicted UFV for a patient. In some embodiments, the UFV determination process may include training a computational model to generate a predicted UFV output based on input of patient characteristics, PD prescription information, PD outcomes (for instance, UFV), and/or historical information associated with patient characteristics, PD prescription information, and/or PD outcomes. In some embodiments, a feedback control process with continuous Intraperitoneal Pressure (IPP) and hydration status measurements may be used to keep the hydration status of the patient within a target level ran. Other embodiments are described.

Abstract: The present invention relates to a method for calculating or approximating a value representing the relative blood volume (RBV) at a certain point of time, or a value representing the refilling volume of a patient that may be observed or found during or due to a blood treatment of the patient, the method involving considering one or more calculated or measured value(s) reflecting an overhydration level of the patient or an approximation thereof. It relates further to an apparatus and a device for carrying out the present invention, a blood treatment device, digital storage means, a computer program product, and a computer program.

Abstract: The present invention relates to an apparatus for performing peritoneal dialysis, the apparatus comprising means for delivering dialysis fluid to the peritoneal cavity of a patient, a measurement device for measuring the fluid pressure of the delivered dialysis fluid and/or the fluid pressure in the peritoneal cavity, i. e. the intraperitoneal pressure and/or any pressure related thereto, and a control unit operably connected to said means and the measurement device, wherein the control unit is configured to effect an inflow or outflow phase encompassing a series of fill-and-measurement or drain-and-measurement steps, each step comprising delivering a predetermined quantity of dialysis fluid to the peritoneal cavity or draining a predetermined quantity of dialysis fluid from the peritoneal cavity and subsequently measuring and recording a pressure value.

Abstract: A medical treatment machine, such as a home dialysis machine, can receive prescription parameters that define parameters of a medical treatment to be administered to a patient. A medical prescription is entered by a clinician into a clinical information system (CIS) that calls a system to evaluate the compatibility of the entered prescription by transmitting the prescription parameters to a server that has access to a database of medical devices and their operational parameters. The server compares the treatment parameters of the medical prescription to the operational parameters of the medical device and generates a prescription compatibility response indicting if the treatment parameters of the medical prescription can be executed by the medical device. The server returns to the CIS the prescription compatibility response to allow the prescription, e.g. in a digital or program form, to be securely transmitted or delivered via a connected health system to the medical device.

Abstract: A medical treatment machine, such as a home dialysis machine, can receive prescription parameters that define parameters of a medical treatment to be administered to a patient. A medical prescription is entered by a clinician into a clinical information system (CIS) that calls a system to evaluate the compatibility of the entered prescription by transmitting the prescription parameters to a server that has access to a database of medical devices and their operational parameters. The server compares the treatment parameters of the medical prescription to the operational parameters of the medical device and generates a prescription compatibility response indicting if the treatment parameters of the medical prescription can be executed by the medical device. The server returns to the CIS the prescription compatibility response to allow the prescription, e.g. in a digital or program form, to be securely transmitted or delivered via a connected health system to the medical device.

Abstract: The present invention relates to an apparatus for performing peritoneal dialysis, the apparatus comprising means for delivering dialysis fluid to the peritoneal cavity of a patient, a measurement device for measuring the fluid pressure of the delivered dialysis fluid and/or the fluid pressure in the peritoneal cavity, i.e. the intraperitoneal pressure and/or any pressure related thereto, and a control unit operably connected to said means and the measurement device, wherein the control unit is configured to effect an inflow or outflow phase encompassing a series of fill-and-measurement or drain-and-measurement steps, each step comprising delivering a predetermined quantity of dialysis fluid to the peritoneal cavity or draining a predetermined quantity of dialysis fluid from the peritoneal cavity and subsequently measuring and recording a pressure value.

Abstract: The present disclosure relates to methods for determining at least one treatment modality of a dialysis treatment of a specific patient depending on at least one value out of the group of values, a first value reflecting the overhydration (OH) of the patient, a second value reflecting the salinity or osmolarity of the patient, a third value reflecting the blood pressure of the patient, a fourth value reflecting the renal function of the patient, a fifth value reflecting a heart issue the patient, a sixth value reflecting hypotension of the patient, a seventh value reflecting vessel conditions, and an eighth value reflecting a total protein content of the patient. Herein, an algorithm or reference material is used. Furthermore, the disclosure relates to devices for executing this method and processing the results of the method.

Abstract: A method and an apparatus for determining or approximating a patient's glomerular filtration rate or a patient's creatinine clearance are disclosed. The method comprises the following steps: determining a serum creatinine concentration of the patient, determining a lean tissue mass of the patient, and determining the glomerular filtration rate of the patient or the creatinine clearance of the patient based on the serum creatinine concentration of the patient and the lean tissue mass of the patient.